Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
How do you prefer to address the inflammatory arthritis component of disease in a patient with RA and ILD who is already on mycophenolate for the ILD?
Related Questions
Would you consider prescribing a JAK inhibitor for a patient with a history of DVT who is on chronic anticoagulation, or would the thrombotic risk deter you?
How do you manage pleuroparenchymal fibroelastosis in a patient with seronegative RA that is progressing on Rituxan and DMARD therapy?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
What is your approach to explaining the role of the microbiome to patients with inflammatory arthritis?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
Can serological markers such as KL-6, MMP-7, and anti-CarP be used to monitor interstitial lung disease in patients with rheumatoid arthritis in clinical practice?
How do you taper corticotropin injections (Acthar) in patients with rheumatologic disease?
How do you guide patients who seek online information about their disease to ensure it is accurate, supports their understanding, and minimizes unnecessary anxiety?
How do you manage rheumatoid arthritis that flares when an adjunctive NSAID is withdrawn despite otherwise stable DMARD therapy?
